Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
10/03/2000 | US6127398 An enzyme inhibitor for the inhibition of phosphodiesterase typeiv or the production of tumor necrosis factor in a mammal; treating asthma, arthritis, bronchitis, chronic obstructive airway disease, psoriasis, allergic rhinitis |
10/03/2000 | US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease |
10/03/2000 | US6127376 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
10/03/2000 | US6127367 Administering an aldose reductase inhibitor as an antiischemic agent |
10/03/2000 | US6127365 Tachykinin antagonists for treatment of pain, inflammation, migraine, emesis and postherpetic neuralgia. |
10/03/2000 | US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof |
10/03/2000 | CA2190180C Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders |
09/30/2000 | CA2302886A1 A stable aqueous solution of em 12 |
09/28/2000 | WO2000057186A1 Method for detecting predisposition to a venous thromboembolic disease |
09/28/2000 | WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites |
09/28/2000 | WO2000056891A2 Human transmembrane proteins |
09/28/2000 | WO2000056890A1 Human fgf gene and gene expression products |
09/28/2000 | WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
09/28/2000 | WO2000056882A1 48 human secreted proteins |
09/28/2000 | WO2000056881A1 48 human secreted proteins |
09/28/2000 | WO2000056862A1 Human tumor necrosis factor receptor tr9 |
09/28/2000 | WO2000056772A1 Human antibodies that bind human il-12 and methods for producing |
09/28/2000 | WO2000056767A1 46 human secreted proteins |
09/28/2000 | WO2000056766A1 47 human secreted proteins |
09/28/2000 | WO2000056765A1 48 human secreted proteins |
09/28/2000 | WO2000056755A1 49 human secreted proteins |
09/28/2000 | WO2000056754A1 48 human secreted proteins |
09/28/2000 | WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
09/28/2000 | WO2000056729A1 Chemokine recpetor binding heterocyclic compounds |
09/28/2000 | WO2000056718A1 Imidazole compounds |
09/28/2000 | WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
09/28/2000 | WO2000056704A1 Hydroxamic and carboxylic acid derivatives |
09/28/2000 | WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
09/28/2000 | WO2000056363A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist |
09/28/2000 | WO2000056360A2 Vaccine against antigens from bacteriae |
09/28/2000 | WO2000056359A2 Vaccine against streptococcus pneumoniae |
09/28/2000 | WO2000056358A2 Vaccine against streptococcus pneumoniae capsular polysaccharides |
09/28/2000 | WO2000056349A1 Treatment with small peptides to effect antifibrotic activity |
09/28/2000 | WO2000056331A1 Inhibitors of impdh enzyme |
09/28/2000 | WO2000056314A1 Method of treating sleep apnoea |
09/28/2000 | WO2000056312A1 Treatment of pulmonary hypertension |
09/28/2000 | WO2000056304A2 Anti-inflammatory uses of manzamines |
09/28/2000 | WO2000045878A3 Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor |
09/28/2000 | WO2000039103B1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines |
09/28/2000 | WO2000035428A3 Tricyclic nitrogen heterocycles as pde iv inhibitors |
09/28/2000 | WO2000022143A3 Protein kinase homologs |
09/28/2000 | WO2000015793A3 Human gpcr proteins |
09/28/2000 | CA2669512A1 Human antibodies that bind human il-12 and methods for producing |
09/28/2000 | CA2368223A1 48 human secreted proteins |
09/28/2000 | CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors |
09/28/2000 | CA2368047A1 Chemokine receptor binding heterocyclic compounds |
09/28/2000 | CA2367963A1 Hydroxamic and carboxylic acid derivatives |
09/28/2000 | CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
09/28/2000 | CA2367620A1 47 human secreted proteins |
09/28/2000 | CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites |
09/28/2000 | CA2367464A1 Materials and methods relating to modulation of p66 expression |
09/28/2000 | CA2367048A1 Treatment with small peptides to effect antifibrotic activity |
09/28/2000 | CA2367025A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist |
09/28/2000 | CA2367022A1 Method of treating sleep apnoea |
09/28/2000 | CA2366691A1 48 human secreted proteins |
09/28/2000 | CA2366652A1 Treatment of pulmonary hypertension |
09/28/2000 | CA2366555A1 Method for detecting predisposition to a venous thromboembolic disease |
09/28/2000 | CA2366152A1 Streptococcus pneumoniae vaccine |
09/28/2000 | CA2366132A1 48 human secreted proteins |
09/28/2000 | CA2365296A1 Vaccine |
09/28/2000 | CA2365255A1 Human tumor necrosis factor receptor tr9 |
09/28/2000 | CA2365247A1 49 human secreted proteins |
09/28/2000 | CA2365243A1 Human transmembrane proteins |
09/28/2000 | CA2365238A1 48 human secreted proteins |
09/28/2000 | CA2365223A1 46 human secreted proteins |
09/27/2000 | EP1038872A1 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands |
09/27/2000 | EP1037888A1 ($i(E))-3- 1-$i(N)-BUTYL- 5- 2-(2-CARBOXYPHENYL)METHOXY- 4-CHLOROPHENYL]-1$i(H)- PYRAZOL-4-YL]-2- (5- METHOXY-2,3- DIHYDROBENZOFURAN-6-YL)METHYL]- PROP-2-ENOIC ACID MONOARGININYL SALT |
09/27/2000 | EP1037887A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
09/27/2000 | EP1037883A1 NOVEL HETEROCYCLICALLY SUBSTITUTED $g(a)-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS |
09/27/2000 | EP1037868A2 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
09/27/2000 | EP1037661A1 ribH |
09/27/2000 | EP1037660A1 ribB |
09/27/2000 | EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
09/27/2000 | EP1037654A1 ribA |
09/27/2000 | EP1037653A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
09/27/2000 | EP1037651A1 Small peptides and methods for treatment of asthma and inflammation |
09/27/2000 | EP1037635A1 Compounds and methods |
09/27/2000 | EP1037620A1 Use of formoterol in medicament for inflammation/allergy in upper airways |
09/27/2000 | EP1037619A2 Selected c 10? perfluorinated hydrocarbons for liquid ventilation and artificial blood |
09/27/2000 | EP1037617A1 Substituted amidino compounds in the treatment of chronic obstructive pulmonary disease |
09/27/2000 | EP1037604A1 Pharmaceutical aerosol compositions |
09/27/2000 | EP0918792B1 Dipeptide benzamidine as a kininogenase inhibitor |
09/27/2000 | EP0733052B1 Bicyclene derivatives, their production and use |
09/27/2000 | EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
09/27/2000 | CN1268138A Compounds |
09/27/2000 | CN1268122A Branched alkoxy- substituted 2-aminopyridines as NOS inhibitors |
09/27/2000 | CN1268056A Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases |
09/27/2000 | CN1268050A Pharmaceutical composition for combination of piperidinoalkanol-decongestant |
09/27/2000 | CN1267532A Biaining as one medicine for nasopharyngeal cancer |
09/27/2000 | CN1056836C 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles and producing process thereof and their use as medicaments |
09/26/2000 | US6124456 Adenosine antagonists |
09/26/2000 | US6124320 Treating with non-sedating antihistamines without causing cardiac arrhythmias |
09/26/2000 | US6124316 Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
09/26/2000 | US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
09/26/2000 | US6124288 Phosphodiesterase iv inhibitors |
09/26/2000 | US6124279 Neurokinin a antagonists, antiasthmatic agents |
09/26/2000 | US6124263 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
09/26/2000 | US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides |
09/26/2000 | CA2126244C Suspension aerosol formulations |
09/21/2000 | WO2000055332A2 Human regulators of intracellular phosphorylation |